(Q38059853)

English

Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

hypertrophic cardiomyopathy

1 reference

based on heuristic

inferred from title

author name string

Stefan A J Timmer

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Paul Knaapen

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

publication date

14 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

European heart journal cardiovascular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

95-101

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Hypertrophic cardiomyopathy: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Myocardial energetics and efficiency: current status of the noninvasive approach

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis.

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the α-tropomyosin gene: A positron emission tomography study

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FEHJCI%2FJES242

21 January 2018

Identifiers

10.1093/EHJCI/JES242

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38059853&oldid=1738909860"